Status:
COMPLETED
Robotic Assisted TKA
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Total Knee Replacement
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
As an intraoperative tool, a modern robotic total knee arthroplasty (TKA) system should be able to identify a patient's native femoral and tibial anatomy, as well as, assess ligament tension and gap b...
Eligibility Criteria
Inclusion
- All unilateral primary knee arthroplasties performed by the investigator participating in this study will be eligible for inclusion
- Diagnosis of primary osteoarthritis
Exclusion
- Revision surgery
- Bilateral knee surgery
- Age \<18 or \>80
- BMI \>40
- Baseline lower extremity strength less than 5/5
- History of chronic narcotic use, defined as more than 5mg of oxycodone q4 hours
- Functionally limiting spine disease
- Other functionally limiting lower extremity disorder (i.e. symptomatic ipsilateral hip disease)
- Patients who cannot perform the baseline functional tests
- Allergy/contraindication to protocol medications
- Post-traumatic arthritis
- Inflammatory arthritis
- Pregnancy
- Prisoners
- Patients receiving care as a result of a worker's compensable injury
- General anesthesia
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06062615
Start Date
July 1 2022
End Date
December 31 2023
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107